These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 25588355
21. Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomes. Mills KA, Mari Z, Pontone GM, Pantelyat A, Zhang A, Yoritomo N, Powers E, Brandt J, Dawson TM, Rosenthal LS. Parkinsonism Relat Disord; 2016 Dec; 33():107-114. PubMed ID: 27733275 [Abstract] [Full Text] [Related]
27. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset. Hanna-Pladdy B, Pahwa R, Lyons KE. J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830 [Abstract] [Full Text] [Related]
28. Executive functioning in obstructive sleep apnea syndrome patients without comorbidities: focus on the fractionation of executive functions. Borges JG, Ginani GE, Hachul H, Cintra FD, Tufik S, Pompéia S. J Clin Exp Neuropsychol; 2013 Apr; 35(10):1094-107. PubMed ID: 24295424 [Abstract] [Full Text] [Related]
29. Sleep spindles in Parkinson's disease may predict the development of dementia. Latreille V, Carrier J, Lafortune M, Postuma RB, Bertrand JA, Panisset M, Chouinard S, Gagnon JF. Neurobiol Aging; 2015 Feb; 36(2):1083-90. PubMed ID: 25442116 [Abstract] [Full Text] [Related]
30. "DASH" symptoms in patients with Parkinson's disease: red flags for early cognitive decline. Naismith SL, Lewis SJ. J Clin Neurosci; 2011 Mar; 18(3):352-5. PubMed ID: 21237647 [Abstract] [Full Text] [Related]
31. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease. Daniels C, Krack P, Volkmann J, Pinsker MO, Krause M, Tronnier V, Kloss M, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G, Witt K. Mov Disord; 2010 Aug 15; 25(11):1583-9. PubMed ID: 20589868 [Abstract] [Full Text] [Related]
32. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Martinez-Martin P, Visser M, Rodriguez-Blazquez C, Marinus J, Chaudhuri KR, van Hilten JJ, SCOPA-Propark Group, ELEP Group. Mov Disord; 2008 Sep 15; 23(12):1681-8. PubMed ID: 18709672 [Abstract] [Full Text] [Related]
39. Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES). Benito-León J, Louis ED, Posada IJ, Sánchez-Ferro Á, Trincado R, Villarejo A, Mitchell AJ, Bermejo-Pareja F. J Neurol Sci; 2011 Nov 15; 310(1-2):176-82. PubMed ID: 21774946 [Abstract] [Full Text] [Related]
40. Future thinking in Parkinson's disease: an executive function? de Vito S, Gamboz N, Brandimonte MA, Barone P, Amboni M, Della Sala S. Neuropsychologia; 2012 Jun 15; 50(7):1494-501. PubMed ID: 22406693 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]